Physician profile
Sherry S Collawn
NPI 1730289828
$3,637.56
in general payments reported to CMS, 2019-2025
16 companies · $1,704 in 2025
The $1,704 reported for 2025 was more than what 82% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $790 · 2020: $132 · 2021: $82.51 · 2022: $141 · 2023: $119 · 2024: $669 · 2025: $1,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,617 · Consulting Fee: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,617.32 |
| Consulting Fee | $875.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $1,229.56 | 2024-2025 | Recell, Permeaderm, Cohealyx |
| Allergan, INC. | $628.45 | 2019-2020 | |
| Integra Lifesciences Corporation | $279.28 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Abbvie INC. | $219.29 | 2024 | |
| Access Pro Medical, LLC | $175.03 | 2025 | Matriderm |
| Motiva USA, LLC | $154.51 | 2025 | |
| Tela Bio, INC. | $148.21 | 2024 | Ovitex 2s |
| Sientra, INC. | $144.68 | 2019 | |
| Rti Surgical, INC | $140.54 | 2022 | |
| Mentor Worldwide LLC | $133.73 | 2019-2023 | Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Galderma Laboratories, L.P. | $124.00 | 2019 | |
| Smith+Nephew, INC. | $123.04 | 2024 | Grafix Pl, Stravix, Renasys Touch |
| Innovation Technologies INC | $82.51 | 2021 | |
| W. L. Gore & Associates, INC. | $27.88 | 2025 | Gore Synecor Preperitoneal Biomaterial |
| Vertex Pharmaceuticals Incorporated | $16.77 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $10.08 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherry Collawn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.